ANI PHARMACEUTICALS ANNOUNCES POSITIVE PHASE 4 OPEN-LABEL, SINGLE-ARM SYNCHRONICITY CLINICAL TRIAL RESULTS PRESENTED AS LATE BREAKING ORAL PRESENTATION AT THE AMERICAN ACADEMY OF OPHTHALMOLOGY 2026 ANNUAL MEETING

Reuters · 2d ago

Please log in to view news